Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients

Diabetes Research and Clinical Practice

Volumn 32, Issue 1-2, 1996, Pages 97-101

  Toplak, H ^a   Haller, E M ^a   Lauermann, T ^a   Weber, K ^a   Bahadori, B ^a   Reisinger, E C ^a   Tilz, G P ^a   Wascher, T C ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chlamydia antibodies; Infection; Metabolic control; Non insulin dependent diabetes mellitus (NIDDM); Serum immunoglobulin levels

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOPEROXIDASE STAINING; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

EID: 0029898376     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01216-8     Document Type: Article

References (20)

1. Infection and diabetes: the case for glucose control
2. Diabetes mellitus und Infektionen
3. Chlamydien
4. Assessing the number of genital chlamydial infections in the United States
5. The epidemiology and significance of Chlamydia pneumoniae
6. Genital infection by Chlamydia trachomatis
7. Chlamydia trachomatis infections — policy guidelines for prevention and control
8. Serumantikörper gegen Chlamydia trachomatis bei Patienten ohne chlamydienspezifisches Krankheitsbild
9. Serum IgG and IgA antibodies specific for Chlamydia trachomatis in salpingitis patients as determined by the immunoperoxidase assay
10. Gamma globulin therapy and immune complexes: some side effects are due to immune complexes and can be influenced by 5S prior to 7S
11. Infection in the diabetic
12. Blood bactericidal studies and serum complement in diabetic patients
13. Comparison of properdin levels in general medical and hematologic patients
14. Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing
15. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes
16. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus
17. Impaired leukocyte function in patients with poorly controlled diabetes
18. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes
19. Neutrophil dysfunction in diabetes mellitus
20. Impairment of polymorphonuclear leukocyte function and metabolic control in diabetes